Staar Surgical Co (STAA) is a publicly traded Healthcare sector company. As of October 21, 2026, STAA trades at $21.61 with a market cap of $1.12B and a P/E ratio of -13.76. STAA moved -3.14% today. Year to date, STAA is -8.43%; over the trailing twelve months it is -19.03%. Its 52-week range spans $14.69 to $35.87. Analyst consensus is neutral with an average price target of $29.14. Rallies surfaces STAA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks STAA insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $21.61 |
| Market Cap | $1.12B |
| P/E Ratio | -13.76 |
| EPS | $-1.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.87 |
| 52-Week Low | $14.69 |
| Volume | 134.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $239.44M |
| Net Income | $-80.45M |
| Gross Margin | 76.19% |
8 analysts cover STAA: 0 strong buy, 3 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $29.14.